Cargando…
Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure()
OBJECTIVE: Measurements of oxidative stress biomarkers in patients with heart failure (HF) have yielded controversial results. This study aimed at testing the hypothesis that circulating levels of the lipid peroxidation product 4-hydroxynonenal bound to thiol proteins (4HNE-P) are strongly associate...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909262/ https://www.ncbi.nlm.nih.gov/pubmed/24494189 http://dx.doi.org/10.1016/j.redox.2013.12.009 |
_version_ | 1782301815333715968 |
---|---|
author | Asselin, Caroline Ducharme, Anique Ntimbane, Thierry Ruiz, Matthieu Fortier, Annik Guertin, Marie-Claude Lavoie, Joël Diaz, Ariel Levy, Émile Tardif, Jean-Claude Des Rosiers, Christine |
author_facet | Asselin, Caroline Ducharme, Anique Ntimbane, Thierry Ruiz, Matthieu Fortier, Annik Guertin, Marie-Claude Lavoie, Joël Diaz, Ariel Levy, Émile Tardif, Jean-Claude Des Rosiers, Christine |
author_sort | Asselin, Caroline |
collection | PubMed |
description | OBJECTIVE: Measurements of oxidative stress biomarkers in patients with heart failure (HF) have yielded controversial results. This study aimed at testing the hypothesis that circulating levels of the lipid peroxidation product 4-hydroxynonenal bound to thiol proteins (4HNE-P) are strongly associated with those of its potential precursors, namely n-6 polyunsaturated fatty acids (PUFA). METHODS AND RESULTS: Circulating levels of 4HNE-P were evaluated by gas chromatography-mass spectrometry in 71 control subjects and 61 ambulatory symptomatic HF patients along with various other clinically- and biochemically-relevant parameters, including other oxidative stress markers, and total levels of fatty acids from all classes, which reflect both free and bound to cholesterol, phospholipids and triglycerides. All HF patients had severe systolic functional impairment despite receiving optimal evidence-based therapies. Compared to controls, HF patients displayed markedly lower circulating levels of HDL- and LDL-cholesterol, which are major PUFA carriers, as well as of PUFA of the n-6 series, specifically linoleic acid (LA; P=0.001). Circulating 4HNE-P in HF patients was similar to controls, albeit multiple regression analysis revealed that LA was the only factor that was significantly associated with circulating 4HNE-P in the entire population (R(2)=0.086; P=0.02). In HF patients only, 4HNE-P was even more strongly associated with LA (P=0.003) and HDL-cholesterol (p<0.0002). Our results demonstrate that 4HNE-P levels, expressed relative to HDL-cholesterol, increase as HDL-cholesterol plasma levels decrease in the HF group only. CONCLUSION: Results from this study emphasize the importance of considering changes in lipids and lipoproteins in the interpretation of measurements of lipid peroxidation products. Further studies appear warranted to explore the possibility that HDL-cholesterol particles may be a carrier of 4HNE adducts. |
format | Online Article Text |
id | pubmed-3909262 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-39092622014-02-03 Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure() Asselin, Caroline Ducharme, Anique Ntimbane, Thierry Ruiz, Matthieu Fortier, Annik Guertin, Marie-Claude Lavoie, Joël Diaz, Ariel Levy, Émile Tardif, Jean-Claude Des Rosiers, Christine Redox Biol Research Paper OBJECTIVE: Measurements of oxidative stress biomarkers in patients with heart failure (HF) have yielded controversial results. This study aimed at testing the hypothesis that circulating levels of the lipid peroxidation product 4-hydroxynonenal bound to thiol proteins (4HNE-P) are strongly associated with those of its potential precursors, namely n-6 polyunsaturated fatty acids (PUFA). METHODS AND RESULTS: Circulating levels of 4HNE-P were evaluated by gas chromatography-mass spectrometry in 71 control subjects and 61 ambulatory symptomatic HF patients along with various other clinically- and biochemically-relevant parameters, including other oxidative stress markers, and total levels of fatty acids from all classes, which reflect both free and bound to cholesterol, phospholipids and triglycerides. All HF patients had severe systolic functional impairment despite receiving optimal evidence-based therapies. Compared to controls, HF patients displayed markedly lower circulating levels of HDL- and LDL-cholesterol, which are major PUFA carriers, as well as of PUFA of the n-6 series, specifically linoleic acid (LA; P=0.001). Circulating 4HNE-P in HF patients was similar to controls, albeit multiple regression analysis revealed that LA was the only factor that was significantly associated with circulating 4HNE-P in the entire population (R(2)=0.086; P=0.02). In HF patients only, 4HNE-P was even more strongly associated with LA (P=0.003) and HDL-cholesterol (p<0.0002). Our results demonstrate that 4HNE-P levels, expressed relative to HDL-cholesterol, increase as HDL-cholesterol plasma levels decrease in the HF group only. CONCLUSION: Results from this study emphasize the importance of considering changes in lipids and lipoproteins in the interpretation of measurements of lipid peroxidation products. Further studies appear warranted to explore the possibility that HDL-cholesterol particles may be a carrier of 4HNE adducts. Elsevier 2013-12-18 /pmc/articles/PMC3909262/ /pubmed/24494189 http://dx.doi.org/10.1016/j.redox.2013.12.009 Text en © 2013 The Authors https://creativecommons.org/licenses/by-nc-nd/3.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License (https://creativecommons.org/licenses/by-nc-nd/3.0/) . |
spellingShingle | Research Paper Asselin, Caroline Ducharme, Anique Ntimbane, Thierry Ruiz, Matthieu Fortier, Annik Guertin, Marie-Claude Lavoie, Joël Diaz, Ariel Levy, Émile Tardif, Jean-Claude Des Rosiers, Christine Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure() |
title | Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure() |
title_full | Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure() |
title_fullStr | Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure() |
title_full_unstemmed | Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure() |
title_short | Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure() |
title_sort | circulating levels of linoleic acid and hdl-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure() |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909262/ https://www.ncbi.nlm.nih.gov/pubmed/24494189 http://dx.doi.org/10.1016/j.redox.2013.12.009 |
work_keys_str_mv | AT asselincaroline circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure AT ducharmeanique circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure AT ntimbanethierry circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure AT ruizmatthieu circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure AT fortierannik circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure AT guertinmarieclaude circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure AT lavoiejoel circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure AT diazariel circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure AT levyemile circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure AT tardifjeanclaude circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure AT desrosierschristine circulatinglevelsoflinoleicacidandhdlcholesterolaremajordeterminantsof4hydroxynonenalproteinadductsinpatientswithheartfailure |